Hodnocení kvality života u pacientů vyššího věku se sarkopenií: vývoj a validace české verze dotazníku SarQoL^®

Česká verzia

Authors: H. Michálková; I. Rýznarová; J. Seget; E. Topinková
Published in the journal: Geriatrie a Gerontologie 2017, 6, č. 1: 28-37
Category:

Summary

Background and aim:
Sarcopenia, defined as loss of muscle mass and muscle function affects between 5–10 % of persons 65 years and older and has significant clinical and economic consequences. In the last year a self-administered quality of life questionnaire for sarcopenia „Sarcopenia and Quality of Life“(SarQoL) was developed in French and English language. To be of use in a different language and socio-cultural environment (i.e. Czech Republic) the questionnaire has to be translated and psychometric properties (internal consistency, validity and reliability) of the Czech version assessed.

Methods:
Translation of the English SarQoL version and its cross-cultural adaptation was performed according to the protocol in five phases: (1) translation to Czech language by two translators, (2) synthesis of both translation into version 1, (3) back translation to English by two translators, (4) experts´ review and creation of working version and (5) testing of the working version in 22 patients with sarcopenia and proposing the final Czech SarQoL version.

Results:
After translation and linguistic adaptation of SarQoL and testing its understandability and feasibility using focus group method involving 10 respondents the final SarQoL version in Czech language was proposed comprising 55 items grouped in 22 questions. There are 7 domains of health-related quality of life assessed by the questionnaire: physical and mental health, locomotion, body composition, functionality, activities of daily living, leisure activities and fears.

Conclusions:
We can recommend the new Czech version of self-administered quality of life questionnaire for sarcopenia SarQoL for further validation and evaluation of its psychometric properties. Validation is currently ongoing in Prague and Opava at authors´ affiliations.

KEYWORDS:
sarcopenia – quality of life – self-administered questionnaire SarQoL

Zdroje

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med 2011; 27: 337–339.

2. Rizzoli R, Reginster, JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013; 93: 101–120.

3. Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas 2012; 71(2): 109–114.

4. Topinková E, Berková M, Mádlová P, Běláček J. „Krátká baterie pro testování fyzické zdatnosti seniorů“ a její využití pro diagnózu geriatrické křehkosti v klinické praxi. Geri a Gero 2013; 1: 43–49.

5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412–423.

6. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre cachexia: joint document elaborated by special interest groups (SIG) ‘‘cachexia-anorexia in chronic wasting diseases’’ and ‘‘nutrition in geriatrics.’’ Clin Nutr 2010; 29: 154–159.

7. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on Sarcopenia. J Am Med Dir Assoc 2011; 12: 249–256.

8. Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. Biol Sci Med Sci 2014; 69(5): 547–558.

9. Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1–7.

10. Fried LP, Xue QL, Cappola AR, Ferrucci L, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 2009; 64(10): 1049–1057.

11. Rockwood K, Stadnyk K, MacKnight C, McDowell I, et al. A brief clinical instrument to classify frailty in elderly people. Lancet 1999; 353(9148): 205–206.

12. Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int. 2012; 23: 1839–1848.

13. Abellan van Kan G, Rolland Y, Bergman H. The I.A.N.A Task force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008; 12(1): 29–37.

14. Kalvach Z, Čeledová L, Holmerová I a kol. Křehký pacient a primární péče. Grada Publishing, Praha 2011; 400 s.

15. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the il SIRENTE study. Clin Nutr 2012; 31(5): 652–658.

16. Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from il SIRENTE study. Age Ageing 2013; 42(2): 203–209.

17. Rodriguez-Manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013 68:62–67.

18. Sayer AA, Syddall HE, Martin HJ, et al. Is grip strength associated with health-related quality of life? Finding from the Hertfordshire Cohort Study. Age Ageing 2006; 35(4):409-415.

19. Beaudart C, Biver E, Reginster JY, et al. Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia. JCSM 2016; 10.1002/12149.

20. Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 2015; 44(6): 960–966.

21. Hendl J. Kvalitativní výzkum: základní metody a aplikace. Praha: Portál 2005; 408 s.